In contrast, the CYP2C19*17 allele, associated with ultra-rapid metabolism, leads to higher 4-OH-TAM levels, correlating with better outcomes and reduced breast cancer recurrence [65]. This evidence concerns the gene CYP2C19 and breast cancer.